Bruker Corporation (BRKR) vs Glaukos Corporation (GKOS)

Bruker Corporation and Glaukos Corporation are both Medical Devices companies. Bruker Corporation and Glaukos Corporation are of similar size ($9.7B and $9.1B). Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 1.65%. Bruker Corporation has the higher net margin (−3.05% vs −30.7%) and the higher return on invested capital (−0.47% vs −26.1%). Across the 18 metrics below, Bruker Corporation leads on 11 and Glaukos Corporation on 7.

Valuation

Metric BRKR GKOS Medical Devices median
P/E n/m n/m 22.18
P/S 2.79 14.82 2.70
P/B 4.07 13.31 2.46
Price to free cash flow 82.24 n/m 22.53
EV/EBITDA 57.15 n/m 11.78
EV/Sales 3.26 14.46 2.38
Earnings yield (1.09%) (2.10%) (8.22%)
Free cash flow yield 1.22% (0.13%) (7.80%)

Profitability

Metric BRKR GKOS Medical Devices median
Gross margin 46.42% 79.12% 56.01%
Operating margin (0.87%) (31.55%) (15.03%)
Net margin (3.05%) (30.68%) (20.40%)
Free cash flow margin 2.68% (1.99%) (7.24%)
Return on equity (5.07%) (25.98%) (15.32%)
Return on assets (1.73%) (19.72%) (19.72%)
Return on invested capital (0.47%) (26.07%) (10.33%)

Growth

Metric BRKR GKOS Medical Devices median
Revenue growth (TTM) 1.65% 41.55% 8.80%
EPS growth (last fiscal year) (119.74%) (18.41%) —
Revenue growth, 5-year CAGR 11.57% 17.67% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRKR GKOS Medical Devices median
Debt to equity 0.76 0.10 0.07
Current ratio 1.85 5.04 2.50
Net debt to EBITDA 5.44 1.31 0.49

Dividend

Metric BRKR GKOS Medical Devices median
Dividend yield 0.21% — 0.94%
Payout ratio 0.09 0.00 0.00

Size

Metric BRKR GKOS Medical Devices median
Market cap 9.74b 9.14b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack